
Amyotrophic lateral sclerosis (ALS) is characterized by progressive degeneration of motor neurons, yet the earliest molecular events that initiate neuronal dysfunction remain poorly understood. A central hallmark of nearly all ALS cases is the nuclear depletion and cytoplasmic mislocalization of the RNA-binding protein TDP-43, leading to widespread disruption of RNA metabolism. While TDP-43 has been extensively studied as a nuclear RNA-binding protein, emerging evidence suggests that many of its pathogenic effects are exerted within axons, where local RNA regulation governs neuronal maintenance, regeneration, and stress responses. Our laboratory investigates how these RNA abnormalities converge on axonal biology to drive neuronal vulnerability.
I will present our recent work demonstrating how TDP-43 controls RNA stability and local RNA programs in neurons, and discuss how disruption of these pathways alters axonal regeneration, retrograde signaling, and neuronal vulnerability. By integrating transcriptomic analyses with human stem cell models and patient tissues, our work identifies mechanisms by which impaired RNA homeostasis disrupts axon-to-nucleus communication, establishing this signaling axis as a critical determinant of neuronal vulnerability in ALS.